share_log

盟科药业(688373.SH)注射用MRX-4序贯康替唑胺片临床试验申请获得欧洲、拉丁美洲国家批准

Mengke Pharmaceutical (688373.SH)'s clinical trial application for MRX-4 sequential contizolamide tablets for injection was approved by European and Latin American countries

Zhitong Finance ·  Nov 3, 2023 04:46

Mengke Pharmaceutical (688373.SH) announced that the company submitted MRs for injectable use in European countries and Latin American countries...

According to the Zhitong Finance App, Mengke Pharmaceutical (688373.SH) announced that the company's drug clinical trial applications for injectable MRX-4 sequential contizolamide tablets for diabetic foot infections submitted by the company in European countries and Latin American countries have been approved by 5 additional countries, allowing clinical trials to be carried out in the UK, Turkey, Georgia, Argentina and Chile.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment